Eledon Pharmaceuticals (ELDN) Tax Provisions (2021)
Eledon Pharmaceuticals' (ELDN) quarterly Tax Provisions came in at -$579000.0 in Q4 2021, up 15.6% on a QoQ basis from -$686000.0 in Q3 2021.
Powered by 
Analysis
Eledon Pharmaceuticals (ELDN) Tax Provisions (2021) Analysis & Trends
Eledon Pharmaceuticals (ELDN) has 1 years of Tax Provisions data on file, last reported at -$579000.0 in Q4 2021.
- Quarterly Tax Provisions changed N/A year-over-year to -$579000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$2.4 million (changed N/A YoY) and the FY2025 annual result came in at $35000.0, down 91.88% from the prior year.
- Tax Provisions improved to -$579000.0 in Q4 2021, from -$686000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of -$501000.0 in Q1 2021 to a low of -$686000.0 in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -59.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 15.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 75.45 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.31 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Eledon Pharmaceuticals | 344.87 Mn | 344.87 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -5.97 Mn |
| Sep 30, 2021 | -686,000.00 |
| Jun 30, 2021 | -588,000.00 |
| Mar 31, 2021 | -501,000.00 |